Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Leah Hubbard

Program Director, Translational Research Program
Division of Cancer Treatment and Diagnosis
Translational Research Program
leah.hubbard@nih.gov

Portfolios: Brain Cancer, Head and Neck Cancer 

Leah Hubbard, PhD is a Program Director in the Translational Research Program in the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). Dr. Hubbard has been a member of the Translational Research Program since 2013 and manages Specialized Programs of Research Excellence (SPOREs) in brain cancer and head and neck cancer. Dr. Hubbard also participates in a number of NCI initiatives, including the U19 Glioblastoma Therapeutics Network RFA. Dr. Hubbard received her PhD in Immunology, and she continued her postdoctoral training at the National Institute of Allergy and Infectious Diseases at NIH. Dr. Hubbard's research training is in the area of innate immunity, with specific expertise in lung macrophage function and host defense; eicosanoid signaling; and syngeneic mouse modeling.

  • Reviewed:
Email